Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Comment by Frictionon Oct 07, 2000 8:12pm

211 Views

Post# 2622890

RE: Tough Week

I am not going to heap blame on anyone...I think the low close is just the nature of the beast. There have been a lot f high expectations created by people hyping th stock in here, and by some positive forward looking comments made by the ceo and by people in IR. This is a great opportunity to pick up more shares at a low price if anyone is inclined. The way I see it, if Conac never aquires or merges, as long as their numbers keep improving this is still a very cheap stock. Happy Thanksgiving. L. Lynch New brunswick

Bullboard Posts

Pinnacle Silver & Gold: A promising precious metals investment